APA (7th ed.) Citation

Paruzzo, L., Bouvier, R., Ghilardi, G., Fardella, E., Fulmer, B., Cohen, I. J., . . . Ruella, M. (2024). Efficacy and Safety of Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-Cell Therapies in Patients with Autoimmune Disease and Lymphoma or Myeloma. Blood, 144(Supplement 1), 7243. https://doi.org/10.1182/blood-2024-206608

Chicago Style (17th ed.) Citation

Paruzzo, Luca, et al. "Efficacy and Safety of Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-Cell Therapies in Patients with Autoimmune Disease and Lymphoma or Myeloma." Blood 144, no. Supplement 1 (2024): 7243. https://doi.org/10.1182/blood-2024-206608.

MLA (9th ed.) Citation

Paruzzo, Luca, et al. "Efficacy and Safety of Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-Cell Therapies in Patients with Autoimmune Disease and Lymphoma or Myeloma." Blood, vol. 144, no. Supplement 1, 2024, p. 7243, https://doi.org/10.1182/blood-2024-206608.